Lenz Therapeutics Inc (LENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,769 | -69,968 | -101,052 | -70,760 | -68,373 |
| Depreciation Amortization | -3,959 | -1,042 | 752 | 734 | 121 |
| Accounts payable and accrued liabilities | -4,279 | 856 | 194 | 1,825 | 594 |
| Other Working Capital | -13,091 | 9,410 | -7,208 | -2,498 | 1,709 |
| Other Operating Activity | 11,707 | 364 | 19,334 | 17,847 | 57,228 |
| Operating Cash Flow | $-59,391 | $-60,380 | $-87,980 | $-52,852 | $-8,721 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -468 | -30 | -6,594 | -5,740 | -1,545 |
| Purchase Of Investment | -241,911 | -52,091 | -405,519 | N/A | N/A |
| Sale Of Investment | 87,900 | 22,500 | 170,250 | N/A | N/A |
| Investing Cash Flow | $-154,479 | $-29,621 | $-241,863 | $-5,740 | $-1,545 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 5,000 |
| Common Stock Issued | 83,551 | 203 | 676 | 623 | 261 |
| Common Stock Repurchased | N/A | N/A | -79 | N/A | N/A |
| Other Financing Activity | 115,451 | 80,497 | 0 | 416,844 | 24,816 |
| Financing Cash Flow | $199,002 | $80,700 | $597 | $417,467 | $30,077 |
| Beginning Cash Position | 35,140 | 44,441 | 378,692 | 19,817 | 6 |
| End Cash Position | 20,272 | 35,140 | 49,446 | 378,692 | 19,817 |
| Net Cash Flow | $-14,868 | $-9,301 | $-329,246 | $358,875 | $19,811 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,391 | -60,380 | -87,980 | -52,852 | -8,721 |
| Capital Expenditure | -468 | -30 | -6,594 | -5,740 | -1,545 |
| Free Cash Flow | -59,859 | -60,410 | -94,574 | -58,592 | -10,266 |